Antiproliferative Fate of the Tetraploid Formed After Mitotic Slippage and Its Promotion; A Novel Target for Cancer Therapy Based on Microtubule Poisons

Molecules - Switzerland
doi 10.3390/molecules21050663
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Consequences of Mitotic Slippage for Antimicrotubule Drug Therapy

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2017English

Up-Regulation of the Mitotic Checkpoint Component Mad1 Causes Chromosomal Instability and Resistance to Microtubule Poisons

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Different Cell Fates After Mitotic Slippage: From Aneuploidy to Polyploidy

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2015English

Post-Slippage Multinucleation Renders Cytotoxic Variation in Anti-Mitotic Drugs That Target the Microtubules or Mitotic Spindle

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2014English

BH4 Domain of BCL-2 as a Novel Target for Cancer Therapy

Drug Discovery Today
Drug DiscoveryPharmacology
2016English

The Pluripotency Factor Musashi-2 Is a Novel Target for Lung Cancer Therapy

Annals of the American Thoracic Society
PulmonaryRespiratory Medicine
2018English

Pancreatic Cancer Stem Cells: Emerging Target for Designing Novel Therapy

Cancer Letters
Cancer ResearchOncology
2013English

Ceramide Synthase 6 Is a Novel Target of Methotrexate Mediating Its Antiproliferative Effect in a P53-Dependent Manner

PLoS ONE
Multidisciplinary
2016English

Novel Roles for P53 in the Genesis and Targeting of Tetraploid Cancer Cells

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy